UBS Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.9M | Buy |
|
|||||
|
2025
Q1 | $19.9M | Sell |
|
|||||
|
2024
Q4 | $27.8M | Sell |
|
|||||
|
2024
Q3 | $33.8M | Sell |
|
|||||
|
2024
Q2 | $41M | Buy |
|
|||||
|
2024
Q1 | $36.5M | Buy |
|
|||||
|
2023
Q4 | $37.5M | Buy |
|
|||||
|
2023
Q3 | $13.8M | Sell |
|
|||||
|
2023
Q2 | $17.4M | Sell |
|
|||||
|
2023
Q1 | $16.5M | Sell |
|
|||||
|
2022
Q4 | $16.3M | Sell |
|
|||||
|
2022
Q3 | $25M | Sell |
|
|||||
|
2022
Q2 | $26.7M | Sell |
|
|||||
|
2022
Q1 | $42.7M | Sell |
|
|||||
|
2021
Q4 | $81.3M | Buy |
|
|||||
|
2021
Q3 | $88.5M | Sell |
|
|||||
|
2021
Q2 | $132M | Sell |
|
|||||
|
2021
Q1 | $138M | Buy |
|
|||||
|
2020
Q4 | $112M | Buy |
|
|||||
|
2020
Q3 | $67.1M | Buy |
|
|||||
|
2020
Q2 | $48.4M | Buy |
|
|||||
|
2020
Q1 | $17.5M | Buy |
|
|||||
|
2019
Q4 | $8.69M | Buy |
|
|||||
|
2019
Q3 | $7.13M | Sell |
|
|||||
|
2019
Q2 | $8.9M | Buy |
|
|||||
|
2019
Q1 | $5.7M | Buy |
|
|||||
|
2018
Q4 | $3.08M | Sell |
|
|||||
|
2018
Q3 | $6.43M | Buy |
|
|||||
|
2018
Q2 | $4.25M | Buy |
|
|||||
|
2018
Q1 | $1.58M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $29K | Sell |
|
|||||
|
2016
Q3 | $47K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $16K | Sell |
|
|||||
|
2015
Q4 | $36K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $13K | Buy |
|
|||||
|
2015
Q1 | $9K | Sell |
|
|||||
|
2014
Q4 | $53K | Buy |
|